We are monitoring the impact of COVID-19 on North America Aptamers Market Get in touch with us for detailed analysis Know More
Share on

North America Aptamers Market Research Report - Segmented By Type, Application, End User, & Country (the United States, Canada & Rest of North America) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 1072
Pages: 145

North America Aptamers Market Size (2022 to 2027)

The size of the North America Aptamers Market was valued at USD 77.92 Million in 2022 and predicted to grow USD 167.21 Million by the end of 2027, growing at a CAGR of 16.50% between 2022 to 2027. 

The North American Aptamers market is expected to be driven by the increasing incidence of life-threatening diseases like cancer and increasing research and development activities. For example, cancer has prompted many companies to develop novel and effective detection tests based on aptamer treatment. In addition, the major pharmaceutical and biotechnology industries are investing in research and development activities which are expected to encourage market growth.  

The market growth is further estimated to be driven by the low cost and high efficiency of Aptamers to large molecules to antibodies. Also, the numerous benefits that these small molecules provide over conventional antibodies have resulted in increased demand for these compounds in various medicinal applications. In addition, they're chemically produced, so there's no batch-to-batch variance, and development takes less time.

On the other hand, the advancements in the aptamer development technologies and the availability of advancements in the healthcare infrastructure are fuelling the market growth. For example, Ultramers, a new product from Integrated DNA Technologies, Inc., comprises aptamer templates with lengths up to 200 bases. According to the company, this new product will be ideal for biotechnology applications such as gene and clone creation. As a result, recent advancements in this industry are projected to increase the use of these goods in various applications, resulting in market growth.

Moreover, the increasing investments and funding by the government and private organizations for the development of healthcare infrastructure are also expected to contribute to the market growth. 

On the other hand, many aptamers have failed to meet clinical trials' safety and effectiveness requirements. As a result, during late-stage clinical investigations, businesses must stop clinical research. This aspect is expected to have a negative impact on the market's growth. Furthermore, additional issues such as a lack of awareness of these technologies in the middle- and low-income countries and an insufficient regulatory structure may hinder overall expansion.

This research report has been segmented and sub-segmented the North American aptamers market into the following categories:

By Type:

  • Peptide aptamers
  • Nucleic Acid aptamers
    • DNA-Based Aptamers
    • RNA-Based Aptamers
    • XNA-Based Aptamers

By Application:

  • Therapeutics Development
  • Diagnostics
  • Research and Development

By End User:

  • Pharmaceutical Companies
  • Bio-Pharmaceutical companies
  • Academic and Research Centres

By Country: 

  • The United States
  • Canada
  • Rest of North America

Geographically, the North American aptamers market dominated the global market in 2020 and is estimated to register healthy CAGR during the forecast period due to the availability of advanced healthcare infrastructure, technological advancements, and increasing pharmaceutical and biotechnology industries' investments in research and development activities. As a result, aptamers are now being utilized to diagnose a variety of diseases and detect tiny compounds. In addition, aptamers can be utilized as functional proteomic levels and pharmaceutical lead section reagents. Also, the presence of the largest economies such as the U.S. and Canada significantly contributes to the North American market growth.

The U.S. aptamers market is anticipated to witness a prominent share in the Aptamers Market. The advancing healthcare sector, favorable reimbursement policies, and the increased applications of aptamers in the food and chemicals industries are fuelling the Aptamers market. In addition, the key market players are investing in R&D activities which are expected to provide lucrative growth opportunities for the new market players.

On the other hand, the Canadian Aptamers market is projected to record a promising share and contribute to the North American regional market growth. The rising focus on the research and development activities in biotechnology and the pharmaceutical sector to introduce innovative pharmaceutical drugs. Increasing demand for aptamers and related products from research institutions is expected to drive market growth.

KEY MARKET PLAYERS:

Companies playing a prominent role in the North American aptamers market profiled in this report are AM Biotechnologies, Aptagen, Aptamer Sciences Inc, Aptamer Solutions Ltd, Aptus Biotech S.L, Base Pair Biotechnologies Inc, NeoVentures Biotechnology Inc, SomaLogic Inc, TriLink BioTechnologies Inc., and Vivonics, Inc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 By Type                        

                                5.1.1 Peptide Aptamers

                                5.1.2 Nucleic Acid Aptamers       

                                                5.1.2.1 DNA-Based Aptamers

                                                5.1.2.2 RNA-Based Aptamers

                                                5.1.2.3 XNA-Based Aptamers

                5.2 By Application                           

                                5.2.1 Therapeutics Development             

                                5.2.2 Diagnostics             

                                5.2.3 Research and Developments          

                5.3 By End Users                             

                                5.3.1 Pharmaceutical Companies             

                                5.3.2 Bio-Pharmaceutical Companies     

                                5.3.3 Academic and Research Centers    

6. Geographical Analysis                                              

                                6.1 Introduction              

                                6.2 United States            

                                6.3 Canada         

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 AM Biotechnologies               

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues            

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Aptagen                      

                8.3 Aptamer Sciences Inc.                            

                8.4 Aptamer Solutions Ltd                           

                8.5 Aptus Biotech S.L.                    

                8.6 Base Pair Biotechnologies Inc                             

                8.7 NeoVentures Biotechnology Inc.                       

                8.8 SomaLogic Inc                           

                8.9 TriLink BioTechnologies Inc                  

                8.10 Vivonics, Inc                            

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Expert Opinions                                         

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  1. North America Aptamers Market, By Type, From 2022 - 2027 (USD Million)
  2. North America Peptide Aptamers Market, By Region, From 2022 - 2027 (USD Million)
  3. North America Nucleic Acid Aptamers Market, By Region, From 2022 - 2027 (USD Million)
  4. North America Aptamers Market, By Application, From 2022 - 2027 (USD Million)
  5. North America Therapeutics Development Market, By Region, From 2022 - 2027 (USD Million)
  6. North America Diagnostics Market, By Region, From 2022 - 2027 (USD Million)
  7. North America Research and Development Market, By Region, From 2022 - 2027 (USD Million)
  8. North America Aptamers Market, By End-users, From 2022 - 2027 (USD Million)
  9. North America Pharmaceutical Companies Market, By Region, From 2022 - 2027 (USD Million)
  10. North America Bio-Pharmaceutical Companies Market, By Region, From 2022 - 2027 (USD Million)
  11. North America Academic and Research centers Market, By Region, From 2022 - 2027 (USD Million)
  12. United States Aptamers Market, By Type, From 2022 - 2027 (USD Million)
  13. United States Aptamers Market, By Application, From 2022 - 2027 (USD Million)
  14. United States Aptamers Market, By End-users, From 2022 - 2027 (USD Million)
  15. Canada Aptamers Market, By Type, From 2022 - 2027 (USD Million)
  16. Canada Aptamers Market, By Application, From 2022 - 2027 (USD Million)
  17. Canada Aptamers Market, By End-users, From 2022 - 2027 (USD Million)
  18. North America Aptamers Market, By Nucleic Acid Aptamers, From 2022 - 2027 (USD Million)
  19. North America DNA Based Aptamers Market, By Region, From 2022 - 2027 (USD Million)
  20. North America RNA Based Aptamers Market, By Region, From 2022 - 2027 (USD Million)
  21. North America XNA Based Aptamers Market, By Region, From 2022 - 2027 (USD Million)
  22. United States Aptamers Market, By Nucleic Acid Aptamers, From 2022 - 2027 (USD Million)
  23. Canada Aptamers Market, By Nucleic Acid Aptamers, From 2022 - 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample